Page last updated: 2024-08-25

rosiglitazone and Anoxia-Ischemia, Brain

rosiglitazone has been researched along with Anoxia-Ischemia, Brain in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Egea, J; García, AG; López, MG; Martínez, A; Rosa, AO1

Other Studies

1 other study(ies) available for rosiglitazone and Anoxia-Ischemia, Brain

ArticleYear
Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors.
    Experimental neurology, 2008, Volume: 212, Issue:1

    Topics: Anilides; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Glucose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoxia-Ischemia, Brain; L-Lactate Dehydrogenase; Male; MAP Kinase Signaling System; Neuroprotective Agents; Organ Culture Techniques; Phosphorylation; PPAR gamma; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Thiadiazoles; Thiazolidinediones

2008